COPD and Lung Diseases

Welcome Message

It is our great pleasure to welcome you to the 4th International Conference on COPD and Lung Diseases (COPD Summit 2026), taking place on November 26–27, 2026, in Rome, Italy. Guided by the theme, Advancing Respiratory Health: Innovations in COPD and Lung Diseases, this premier international conference will bring together renowned pulmonologists, respiratory physicians, researchers, clinicians, academicians, healthcare professionals, students, industry experts, and policymakers from across the globe to exchange knowledge, share innovative research, and strengthen collaborations in respiratory medicine.

COPD Summit 2026 provides a dynamic platform for scientific exchange, professional development, and interdisciplinary collaboration. The conference will feature keynote lectures, plenary sessions, oral and poster presentations, panel discussions, and networking opportunities focused on the latest advances in COPD, lung diseases, respiratory diagnostics, emerging therapies, precision medicine, digital health, and other evolving areas of pulmonary science. Participants will have the opportunity to present their research, gain insights from internationally recognized experts, and engage in meaningful discussions that support excellence in respiratory care and research.

We are delighted to welcome our distinguished speakers, delegates, sponsors, exhibitors, and partners to COPD Summit 2026. We look forward to two inspiring days of scientific learning, meaningful networking, and international collaboration that will foster innovation, strengthen professional partnerships, and contribute to improving respiratory health and patient outcomes worldwide. 

About Conference

The 4^th International Conference on COPD and Lung Diseases (COPD Summit 2026) will be held on November 26–27, 2026, in Rome, Italy, under the theme Advancing Respiratory Health: Innovations in COPD and Lung Diseases. As a leading international scientific conference, COPD Summit 2026 is dedicated to promoting excellence in respiratory medicine by bringing together experts from academia, clinical practice, research institutions, healthcare organizations, industry, and government. The conference provides an ideal platform for sharing scientific knowledge, fostering interdisciplinary collaboration, and exploring innovative approaches that address the growing global burden of COPD and lung diseases.

COPD Summit 2026 will be conducted in both in-person and virtual formats, enabling broad participation and meaningful engagement from a global audience. The program is designed to encourage the presentation of original research, clinical case studies, technological innovations, and evidence-based practices through keynote lectures, scientific sessions, oral and poster presentations, panel discussions, and interactive networking opportunities. Participants will have the opportunity to exchange ideas, establish international collaborations, and engage with experts committed to advancing respiratory healthcare.

All presenters and registered participants will receive an official certificate of participation from the Organizing Committee, recognizing their valuable contribution to the conference. Outstanding oral and poster presentations will be honored with special awards in recognition of scientific excellence and innovation in respiratory medicine. Whether attending in person or virtually, delegates will gain valuable professional insights, expand their global network, and contribute to shaping the future of respiratory research and clinical practice. 

Why to Attend

The 4th International Conference on COPD and Lung Diseases (COPD Summit 2026) offers an excellent opportunity to stay informed about the latest developments in respiratory medicine while connecting with experts from around the world. Whether you are a researcher, clinician, healthcare professional, academician, student, or industry representative, the conference provides a valuable platform for learning, collaboration, and professional growth.

By attending COPD Summit 2026, you will have the opportunity to:

• Learn about the latest advances in COPD and lung disease research.
• Gain insights from internationally recognized experts and keynote speakers.
• Present your research through oral or poster presentations.
• Exchange ideas and discuss current challenges with global professionals.
• Explore emerging technologies, innovative therapies, and clinical practices.
• Build professional networks and establish international collaborations.
• Receive constructive feedback from experts in the field.
• Discover opportunities for future research and academic partnerships.
• Earn an official certificate of participation from the Organizing Committee.
• Compete for prestigious awards recognizing outstanding oral and poster presentations.

Whether you attend in person in Rome or virtually, COPD Summit 2026 provides a collaborative environment to enhance your knowledge, expand your professional network, and contribute to the advancement of respiratory health worldwide.

Target Audience

• Pulmonologists
• Respiratory Physicians
• Chest Physicians
• Thoracic Surgeons
• Intensivists and Critical Care Specialists
• Physicians
• Asthma Specialists
• Allergy and Immunology Specialists
• Respiratory Therapists
• Pulmonary Rehabilitation Specialists
• Sleep Medicine Specialists
• Lung Cancer Specialists
• Oncologists
• Radiologists
• Pathologists
• Clinical Researchers
• Professors and Academicians
• Postdoctoral Researchers
• Respiratory Care Nurses
• Medical Students
• PhD Scholars
• Healthcare Professionals
• Universities and Medical Colleges
• Healthcare Technology Companies
• Respiratory and Pulmonary Societies
• Hospitals and Healthcare Institutions
• Medical Device Industry Representatives

Sessions & Tracks

Track 1: COPD

Chronic Obstructive Pulmonary Disease (COPD) is a long-term respiratory disease that affects the airways and lungs, making it difficult for people to breathe. It is one of the leading causes of illness and death worldwide and has a significant impact on the quality of life of millions of individuals. COPD is commonly associated with smoking, but it can also develop due to long-term exposure to air pollution, occupational dust and chemicals, biomass fuel smoke, and genetic factors. As the disease progresses, patients may experience persistent cough, breathlessness, frequent respiratory infections, and reduced lung function, highlighting the importance of early diagnosis and appropriate clinical management.

This session will provide a comprehensive overview of COPD, from its underlying mechanisms and risk factors to current approaches in diagnosis, treatment, and long-term disease management. It will cover topics including pulmonary function testing, disease phenotypes, biomarkers, acute exacerbations, COPD-associated comorbidities, pharmacological and non-pharmacological interventions, pulmonary rehabilitation, inhalation therapies, precision medicine, and emerging technologies. The session aims to encourage scientific discussion, promote evidence-based clinical practice, and support the development of effective strategies for improving respiratory health and patient care.

Track 2: COPD: Prevention, Diagnosis & Management

Chronic Obstructive Pulmonary Disease (COPD) is a preventable and manageable respiratory condition, and early intervention plays a key role in slowing disease progression and improving patients' quality of life. Reducing exposure to risk factors, recognizing symptoms at an early stage, and using appropriate diagnostic tools can help achieve timely diagnosis and more effective treatment. Comprehensive disease management, combined with patient education and regular follow-up, is essential for controlling symptoms, preventing exacerbations, and supporting long-term respiratory health. This session will explore current approaches to COPD prevention, diagnosis, and management, with a focus on evidence-based clinical practice and multidisciplinary patient care.

• Smoking Cessation and Risk Factor Reduction
• Early Diagnosis, Screening, and Pulmonary Function Testing
• Pharmacological and Non-Pharmacological Management of COPD
• Pulmonary Rehabilitation and Comprehensive Patient Care
• Clinical Practice Guidelines and Personalized COPD Care

Track 3: COPD: Emerging Therapies & Disease Management

The treatment of Chronic Obstructive Pulmonary Disease (COPD) is continuously evolving as new therapies, technologies, and clinical approaches improve the way the disease is managed. Ongoing research has led to better understanding of COPD progression, enabling more individualized treatment strategies that address the specific needs of each patient. Along with pharmacological therapies, comprehensive disease management now includes pulmonary rehabilitation, lifestyle interventions, patient education, and digital health solutions that support long-term monitoring and continuity of care. This session will highlight recent developments in COPD treatment and disease management, focusing on innovative therapeutic approaches, precision medicine, and integrated care models that aim to improve respiratory health and quality of life.

·         Novel Therapeutic Approaches for COPD

·         Personalized Treatment and Precision Medicine

·         Advanced Inhalation Therapies and Drug Delivery Systems

·         Pulmonary Rehabilitation and Long-Term Disease Management

·         Digital Health, Remote Monitoring, and Clinical Innovations

Track 4: Lung Diseases

Lung diseases encompass a wide range of conditions that affect the lungs and respiratory system, leading to impaired breathing, reduced lung function, and a significant impact on overall health. These conditions may develop due to infections, chronic inflammation, environmental and occupational exposures, genetic factors, or other underlying medical disorders. As respiratory diseases continue to pose major healthcare challenges worldwide, ongoing research and clinical advancements are improving the understanding of disease mechanisms, enabling earlier diagnosis, more accurate assessment, and more effective treatment strategies. This session will provide a broad overview of common and complex lung diseases, highlighting current clinical practices, recent research findings, and multidisciplinary approaches to respiratory care.

·         Chronic Obstructive Pulmonary Disease (COPD)

·         Asthma and Airway Diseases

·         Interstitial Lung Diseases (ILD)

·         Pulmonary Fibrosis

·         Respiratory Infections and Pneumonia

·         Lung Cancer and Thoracic Disorders

·         Pulmonary Hypertension and Pulmonary Vascular Diseases

Track 5: Asthma & Airway Diseases

Asthma and airway diseases are among the most common respiratory conditions affecting people of all ages worldwide. These disorders involve inflammation, narrowing, and increased sensitivity of the airways, leading to symptoms such as coughing, wheezing, shortness of breath, and breathing difficulties. Advances in respiratory medicine have improved the understanding of airway inflammation, disease mechanisms, and treatment approaches, allowing for better diagnosis, symptom control, and personalized care. This session will focus on recent developments in asthma and airway disorders, including innovative therapies, improved management strategies, and emerging research aimed at enhancing respiratory health and patient outcomes.

·         Bronchial Asthma

·         Allergic Asthma and Airway Inflammation

·         Bronchiectasis and Small Airway Diseases

·         Severe Asthma and Biologic Therapies

·         Chronic Airway Disorders and Management Strategies

Track 6: Interstitial Lung Diseases (ILD)

Interstitial Lung Diseases (ILD) include a wide range of disorders that affect the lung tissue and interfere with normal breathing and oxygen exchange. These conditions may develop due to autoimmune disorders, environmental exposures, genetic factors, medications, or unknown causes, and can significantly impact patients’ quality of life. Improved understanding of disease patterns, diagnostic approaches, and treatment options has helped healthcare professionals provide more effective care for individuals with ILD. Ongoing research continues to explore new therapeutic strategies, disease monitoring methods, and personalized approaches to manage these complex respiratory conditions.

·         Idiopathic Pulmonary Fibrosis (IPF)

·         Connective Tissue Disease-Associated ILD

·         Hypersensitivity Pneumonitis

·         Autoimmune-Related Interstitial Lung Diseases

·         Progressive Fibrosing Interstitial Lung Diseases

Track 7: Pulmonary Fibrosis

Pulmonary Fibrosis is a chronic lung disorder considered by the formation of scar tissue in the lungs, which can gradually affect breathing and reduce lung function. The condition may develop due to autoimmune diseases, environmental exposures, certain medications, infections, or unknown causes. Growing research in this field is improving the understanding of disease progression, diagnostic approaches, and treatment options, helping healthcare professionals provide more effective and personalized care. This session will explore key aspects of pulmonary fibrosis, including clinical management, emerging therapies, and ongoing research aimed at improving outcomes for individuals affected by fibrotic lung diseases.

·         Idiopathic Pulmonary Fibrosis (IPF)

·         Progressive Fibrosing Interstitial Lung Diseases

·         Antifibrotic Therapies and Emerging Treatments

·         Biomarkers and Molecular Pathways

·         Supportive Care and Lung Transplantation

Track 8: Respiratory Infections

Respiratory infections are among the most common conditions affecting the lungs and airways, ranging from mild infections to severe illnesses that can significantly affect respiratory function. These infections may be caused by bacteria, viruses, fungi, and other pathogens, making accurate diagnosis and appropriate treatment essential for effective patient care. This session will cover the clinical aspects of respiratory infections, including disease patterns, diagnostic approaches, treatment strategies, antimicrobial challenges, and preventive measures that support better respiratory health.

·         Bacterial Respiratory Infections

·         Viral Respiratory Infections

·         Fungal Lung Infections

·         Pneumonia and Lower Respiratory Tract Infections

·         Antimicrobial Resistance and Treatment Strategies

Track 9: Tuberculosis

Tuberculosis (TB) continues to be a major respiratory health concern, affecting millions of people worldwide, with the lungs being the most commonly affected organ. The disease presents ongoing challenges due to delayed detection, treatment complexity, and the emergence of drug-resistant forms. This session will highlight key areas in tuberculosis care, including diagnosis, treatment approaches, prevention strategies, and current research efforts focused on improving disease control and patient outcomes.

·         Pulmonary Tuberculosis

·         Drug-Resistant Tuberculosis

·         Tuberculosis Diagnosis and Molecular Testing

·         Anti-Tuberculosis Therapies and Treatment Strategies

·         Tuberculosis Prevention and Public Health Control

Track 10: Lung Cancer & Thoracic Oncology

Lung cancer is one of the most common malignancies affecting the respiratory system and remains a major area of focus in thoracic medicine and oncology. It develops due to uncontrolled growth of abnormal cells in the lungs and can present significant challenges in diagnosis, classification, and clinical management. Research in tumor biology, molecular profiling, and multidisciplinary care has expanded the understanding of lung cancer and created new possibilities for improving patient care. This session will explore important areas in thoracic oncology, including disease characteristics, current research findings, and collaborative approaches involving pulmonologists, oncologists, surgeons, radiologists, and other healthcare specialists.

·         Non-Small Cell Lung Cancer (NSCLC)

·         Small Cell Lung Cancer (SCLC)

·         Molecular Classification and Biomarkers in Lung Cancer

·         Immunotherapy and Targeted Cancer Therapies

·         Thoracic Surgery and Multidisciplinary Oncology Care

Track 11: Pulmonary Hypertension

Pulmonary Hypertension is a condition characterized by increased pressure in the blood vessels of the lungs, which can affect the ability of the heart and lungs to function effectively. It may occur as a result of various underlying conditions, including heart diseases, lung disorders, connective tissue diseases, and genetic factors. Understanding the different forms of pulmonary hypertension and their impact on respiratory and cardiovascular health is essential for effective clinical care. This session will explore the classification, disease mechanisms, diagnostic approaches, and current research areas related to pulmonary hypertension, with a focus on improving understanding and advancing patient care.

·         Pulmonary Arterial Hypertension (PAH)

·         Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

·         Pulmonary Hypertension Associated with Lung Diseases

·         Right Heart Function and Cardiopulmonary Interactions

·         Targeted Therapies and Emerging Treatment Approaches

Track 12: Respiratory Diagnostics & Lung Function Testing

Accurate diagnosis plays an important role in understanding respiratory conditions and guiding appropriate clinical decisions. Respiratory diagnostics and lung function testing provide valuable insights into airway function, lung capacity, disease severity, and treatment response. From routine assessments to advanced diagnostic techniques, these tools help healthcare professionals evaluate a wide range of pulmonary disorders and monitor changes over time. This session will explore key diagnostic methods, technological innovations, and clinical approaches that support better evaluation and management of respiratory diseases.

·         Spirometry and Pulmonary Function Tests

·         Advanced Lung Imaging and Diagnostic Techniques

·         Biomarkers and Molecular Diagnostics in Respiratory Diseases

·         Bronchoscopy and Minimally Invasive Diagnostic Procedures

·         Digital Health Tools and Remote Respiratory Monitoring

Track 13: Pulmonary Rehabilitation & Respiratory Care

Pulmonary rehabilitation plays an important role in improving the physical capacity, independence, and quality of life of individuals living with chronic respiratory conditions. Through a combination of exercise training, education, breathing techniques, and supportive care, pulmonary rehabilitation helps patients better manage symptoms and maintain daily activities. Respiratory care professionals also contribute significantly to patient support through monitoring, therapy guidance, and specialized interventions. This session will explore approaches in pulmonary rehabilitation and respiratory care that help better functional results and support comprehensive management of respiratory disorders.

·         Pulmonary Rehabilitation Programs and Exercise Training

·         Breathing Techniques and Respiratory Therapy

·         Oxygen Therapy and Respiratory Support

·         Patient Education and Self-Management Strategies

·         Multidisciplinary Respiratory Care Approaches

Track 14: Critical Care Pulmonology & Mechanical Ventilation

Critical Care Pulmonology focuses on the management of patients with severe respiratory conditions requiring specialized monitoring and intensive care support. Critically ill patients with respiratory failure, severe infections, acute exacerbations, or complex lung disorders often require advanced interventions to maintain adequate breathing and oxygenation. This field combines expertise from pulmonology and critical care to address life-threatening respiratory challenges through timely assessment, supportive therapies, and coordinated patient management. This session will highlight important aspects of intensive respiratory care, including critical illness management, ventilatory support, and approaches to improving outcomes in critically ill patients.

·         Acute Respiratory Failure and Critical Lung Conditions

·         Non-Invasive and Invasive Mechanical Ventilation

·         Acute Respiratory Distress Syndrome (ARDS)

·         Ventilator Management and Weaning Strategies

·         Intensive Care Approaches in Severe Respiratory Diseases

Track 15: Bronchoscopy & Interventional Pulmonology

Bronchoscopy and interventional pulmonology are important areas of respiratory medicine that allow physicians to diagnose and manage complex airway and lung conditions through minimally invasive procedures. These techniques provide valuable information about airway abnormalities, lung lesions, and respiratory disorders while offering therapeutic options for selected conditions. With the growing use of advanced bronchoscopic procedures and image-guided interventions, interventional pulmonology continues to expand its role in modern respiratory care. This session will explore key procedures, clinical applications, and emerging approaches that support accurate evaluation and treatment of complex pulmonary conditions.

·         Diagnostic Bronchoscopy and Airway Evaluation

·         Endobronchial Ultrasound (EBUS) and Lung Cancer Staging

·         Therapeutic Bronchoscopy Procedures

·         Airway Stenting and Management of Airway Disorders

·         Advanced Interventional Pulmonary Techniques

Track 16: Sleep Medicine & Sleep-Related Breathing Disorders

Sleep plays an essential role in maintaining overall health, and disorders affecting breathing during sleep can significantly influence respiratory function and quality of life. Sleep-related breathing disorders are commonly associated with interrupted airflow, oxygen fluctuations, and disturbances in normal sleep patterns. Conditions such as sleep apnea and other nocturnal respiratory problems require proper evaluation and multidisciplinary care. This session will explore important aspects of sleep medicine, including disease mechanisms, diagnostic methods, and clinical approaches for managing sleep-related respiratory conditions.

·         Obstructive Sleep Apnea (OSA)

·         Central Sleep Apnea and Sleep-Related Hypoventilation Disorders

·         Sleep Disorders Associated with Chronic Respiratory Diseases

·         Polysomnography and Sleep Diagnostic Techniques

·         Positive Airway Pressure (PAP) Therapy and Sleep Management

Track 17: Occupational & Environmental Lung Diseases

Occupational and environmental factors play an important role in the development of various respiratory conditions, particularly among individuals exposed to dust, chemicals, pollutants, and other harmful substances. Long-term exposure to workplace hazards and environmental pollutants can contribute to airway disorders, lung inflammation, and chronic respiratory problems. Understanding these risk factors is essential for prevention, workplace safety, and effective clinical care. This session will explore respiratory diseases  linked to occupational and environmental exposures, along with approaches for assessment, prevention, and management of affected individuals.

·         Pneumoconiosis and Occupational Lung Disorders

·         Silicosis, Asbestosis, and Dust-Related Lung Diseases

·         Occupational Asthma and Workplace-Related Airway Diseases

·         Air Pollution and Respiratory Health Effects

·         Prevention Strategies and Workplace Respiratory Safety

Track 18: Pediatric Pulmonology

Pediatric Pulmonology focuses on respiratory conditions affecting infants, children, and adolescents, with emphasis on the unique challenges of developing lungs and airways. Respiratory disorders during childhood can influence growth, daily activities, and long-term lung health, making early recognition and appropriate care important. This session covers a wide range of conditions, from common airway disorders to complex congenital and chronic lung diseases. This session will highlight important areas in pediatric respiratory care, including childhood lung disorders, clinical evaluation, and approaches that support healthy respiratory development.

·         Childhood Asthma and Wheezing Disorders

·         Cystic Fibrosis and Genetic Lung Diseases

·         Congenital and Developmental Lung Disorders

·         Pediatric Sleep-Related Breathing Disorders

·         Childhood Respiratory Infections and Chronic Lung Conditions

Track 19: Current Research & Innovations in Pulmonology

Pulmonology continues to evolve with new discoveries in disease mechanisms, diagnostic approaches, and therapeutic strategies that are shaping the future of respiratory healthcare. Ongoing research is providing deeper insights into complex lung conditions and supporting the development of more targeted and effective approaches for patient care. This session will bring together researchers, clinicians, and healthcare professionals to discuss recent scientific findings, emerging concepts, and innovative solutions that are influencing the field of respiratory medicine.

·         Novel Biomarkers and Molecular Research in Lung Diseases

·         Precision Medicine and Personalized Respiratory Care

·         Regenerative Medicine and Cellular Therapies in Pulmonology

·         Digital Health, Artificial Intelligence, and Smart Respiratory Technologies

·         Emerging Clinical Research and Innovative Therapeutic Approaches

Track 20: Clinical Trials & Translational Respiratory Research

Clinical trials and translational research play an important role in transforming scientific discoveries into practical solutions for respiratory healthcare. By connecting laboratory findings with clinical applications, translational research helps identify new possibilities for diagnosing, treating, and managing complex lung conditions. This area brings together researchers, clinicians, and industry experts to evaluate new therapies, study disease mechanisms, and generate evidence that supports better clinical practices. This session will highlight important research activities that are contributing to the future of respiratory medicine.

·         Clinical Trials in COPD and Lung Diseases

·         Novel Drug Development and Therapeutic Studies

·         Translational Research in Respiratory Disorders

·         Biomarkers and Molecular-Based Research

·         Real-World Evidence and Clinical Practice Applications

Track 21: Artificial Intelligence & Digital Health in Respiratory Medicine

Technology is playing an increasingly important role in transforming respiratory healthcare by supporting better diagnosis, monitoring, and patient management. Artificial intelligence and digital health solutions are helping researchers and clinicians analyze complex medical data, improve clinical decision-making, and develop more efficient approaches to respiratory care. These technologies are creating new possibilities for early risk assessment, personalized care planning, and continuous monitoring of patients with chronic respiratory conditions. The integration of digital tools into clinical practice is also helping improve accessibility, coordination, and quality of respiratory healthcare. This session will explore the role of emerging technologies in shaping the future of respiratory medicine.

·         Artificial Intelligence in Lung Disease Diagnosis and Prediction

·         Digital Monitoring and Remote Patient Care

·         Machine Learning Applications in Respiratory Medicine

·         Wearable Devices and Smart Respiratory Technologies

·         Telemedicine and Digital Healthcare Solutions

Track 22: Future Directions in COPD & Lung Diseases

Respiratory medicine continues to evolve with new scientific discoveries, innovative approaches, and changing healthcare needs shaping the future of COPD and lung disease care. A better understanding of disease mechanisms, patient-centered strategies, and the integration of new technologies are creating opportunities for improved prevention, monitoring, and long-term management of respiratory conditions. This session will explore upcoming priorities in COPD and lung diseases, including emerging research areas, innovative healthcare approaches, and potential pathways that may influence the future of respiratory care.

·         Future Research Priorities in COPD and Lung Diseases

·         Precision Medicine and Personalized Respiratory Care

·         Emerging Therapies and Novel Treatment Approaches

·         Innovative Diagnostic Tools and Monitoring Technologies

·         Global Strategies for Improving Respiratory Health

Market Analysis

The global Chronic Obstructive Pulmonary Disease (COPD) market is experiencing significant growth, driven by the increasing prevalence of respiratory diseases and rising exposure to risk factors such as tobacco smoking, air pollution, and occupational hazards. COPD, which includes chronic bronchitis and emphysema, is a leading cause of morbidity and mortality worldwide, creating a strong demand for effective diagnosis, treatment, and long-term management solutions.

The market is primarily driven by the growing use of pharmacological treatments, including bronchodilators, corticosteroids, and combination therapies, which remain the first line of treatment for managing symptoms and improving patient quality of life. Additionally, increasing healthcare expenditure, advancements in diagnostic techniques, and greater public awareness are contributing to market expansion. Hospitals dominate the end-user segment due to the availability of advanced infrastructure, skilled professionals, and comprehensive care facilities.

Regionally, North America holds the largest market share, supported by strong research and development activities, advanced healthcare systems, and the presence of major industry players. Meanwhile, emerging economies in Asia-Pacific and other developing regions are expected to witness rapid growth due to improving healthcare access, rising awareness, and increasing investments in healthcare infrastructure.

Benefits of Participation

COPD Summit 2026 offers diverse participation opportunities for academic, student, and business professionals. The available categories include:

1. Keynote Speaker: 45–50 minutes presentation
2. Speaker (Oral Presentation): 25–30 minutes (individual presenter)
3. Speaker (Workshop): 45–50 minutes (multiple presenters allowed)
4. Speaker (Special Session): 45–50 minutes (multiple presenters allowed)
5. Speaker (Symposium): More than 45 minutes (multiple presenters allowed)
6. Delegate: Access to all sessions with full registration benefits
7. Poster Presenter: Present a poster and receive delegate benefits
8. Virtual Attendance: Participate via video presentation or e-poster
9. Exhibitor: Showcase products/services through exhibition booths
10. Media Partner
11. Sponsor
12. Collaborator

Advantages of Participating in Our Conference

1. Participants will receive CPD credits along with a certificate of participation.
2. Speaker and abstract profiles indexed by search engines enhance global visibility and professional recognition.
3. Our abstract library attracts over 30,000 monthly visits and 50,000 views, increasing exposure for speakers and researchers.
4. Opportunities for interactive meetings are available, especially for groups attending with research teams.
5. Connect and exchange ideas with leading experts in COPD, asthma, and lung health.
6. Recognition through awards such as Young Scientist Award and Best Poster Certificate.
7. Engage in meaningful one-on-one discussions with distinguished speakers and keynote experts.
8. Gain insights from keynote sessions featuring world-renowned authorities in COPD and pulmonary healthcare.

Benefits of Participation for Speakers

1. All accepted abstracts will be published in relevant journals, enhancing academic recognition.
2. Participants will receive CPD credits along with an official certificate of participation.
3. Gain global visibility and recognition for your research profile.
4. Earn valuable points toward your professional development.
5. Explore the latest cutting-edge research and scientific advancements.
6. Build lasting connections through networking and social interactions.
7. Promote your work through abstract books and flyers, reaching a wide audience and strengthening your research impact.
8. Expand your knowledge by exploring interdisciplinary topics beyond COPD, asthma, and lung health.
9. Experience a well-balanced event that combines networking, learning, and engaging activities.

Benefits of Participation for Delegates

1. Enhance knowledge and skills to support continuous professional development.
2. Stay refreshed, motivated, and inspired by attending engaging conference sessions and webinars.
3. Gain new perspectives and innovative approaches that can be applied to improve professional or organizational outcomes.
4. Connect with scholars and practitioners in COPD, lung health, and respiratory fields to exchange ideas and insights.

Benefits of Participation for Sponsors

1. Enhance brand visibility and expand business opportunities in the global marketplace.
2. Showcase your latest innovations, products, and services to an international audience.
3. Generate high-quality leads and build valuable business connections.
4. Network with like-minded professionals, industry leaders, and potential partners to support business growth.
5. Gain insights and fresh perspectives from COPD and asthma-focused conferences and webinars to strengthen your strategies.
6. Benchmark your organization against industry leaders and explore opportunities for advancement.
7. Address business challenges and gain expert insights through direct interaction with trusted professionals at the conference.

Benefits of Participation for Collaborators

1. Gain exceptional visibility through a high-traffic platform, making COPD Summit 2026 an ideal venue to promote your organization.
2. Build strong, long-term professional relationships with peers and industry experts.
3. Enhance brand presence through logo placement, promotional materials, and conference branding, helping expand your audience and membership base.
4. Increase global recognition by positioning your organization within an international business and research forum.
5. Enable your representatives to engage with key delegates, improving awareness and understanding of your services.
6. Receive promotional exposure through inclusion in conference materials such as posters, brochures, and pamphlets distributed to hospitals, universities, researchers, and the public.